Inhibikase Therapeutics, Inc. - Common Stock (IKT)

2.4750
+0.0750 (3.13%)
NASDAQ· Last Trade: Aug 6th, 10:27 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors